Serum L-selectin and P-selectin levels in lymphomas

Haematologia

Volumn 30, Issue 1, 2000, Pages 27-30

  Haznedaroglu I C ^a   Benekli, M ^a,b   Ozcebe, O ^a   Savas M C ^a   Gullu I H ^a   Dundar S V ^a   Kirazli, S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Hodgkin's disease; L selectin; Non Hodgkin's lymphoma; P selectin

Indexed keywords

L SELECTIN; PADGEM PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CELL ADHESION; DISEASE COURSE; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOMA; MALE; MIDDLE AGED; NONHODGKIN LYMPHOMA; PATHOLOGY;

ADULT; AGED; CELL ADHESION; DISEASE PROGRESSION; FEMALE; HODGKIN DISEASE; HUMANS; L-SELECTIN; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; P-SELECTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033658214     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: 10.1163/15685590051129841     Document Type: Article

References (13)

1. Shimizu, Y., Newman, W., Tanaka, Y., Shaw, S., Lymphocyte interactions with endothelial cells, Immunol. Today 13, 106 (1992).
2. Stoolman, L. M., Adhesion molecules controlling lymphocyte migration, Cell 56, 907 (1989).
3. Bevilacqua, M. P., Nelson, R. M., Selectins, J. Clin. Invest. 91, 379 (1993).
4. Gallatin, W. M., Weissman, I. L., Butcher, E. C., A cell-surface molecule involved in organ-specific homing of lymphocytes, Nature 304, 30 (1983).
5. Bonfanti, R., Furie, B. C., Furie, B., Wagner, D. D., PADGEM (GMP 140) is a component of Weibel-Palade bodies of human endothelial cells, Blood 73, 1109 (1989).
6. +-dependent adhesion of activated platelet to many different types of leukocytes: Detection by flow cytometry, Blood 80, 134 (1992).
7. Pals, S. T., Horst, E., Scheper, R. J., Meijer, C. J. L. M., Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease, Immunol. Rev. 108, 111 (1989).
8. Pals, S. T., Drillenburg, P., Radaszkiewicz, T., Manten-Horst, E., Adhesion molecules in the dissemination of non-Hodgkin's lymphomas, Acta Haematol. 97, 73 (1997).
9. Gruss, H.-J., Dölken, G., Brach, M. A., Mertelsmann, R., Herrmann, F., Serum levels of circulating ICAM-1 are increased in Hodgkin's disease, Leukemia 8, 1245 (1993).
10. Pui C.-H., Luo, X., Evans, W., Martin, S., Rugg, A., Wilimas, J., Crist, W. M., Hudson, M., Serum intercellular adhesion molecule-1 in childhood malignancy, Blood 82, 895 (1993).
11. Christiansen, I., Gidlöf, C., Wallgren, A. C., Simonsson, B., Tötterman, T. H., Serum levels of soluble intercellular adhesion molecule-1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers, Blood 84, 3010 (1994).
12. Christiansen, I., Gidlöf, C., Kalkner, K.-M., Hagberg, H., Bennmarker, H., Tötterman, T., Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers, Br. J. Haematol. 92, 639 (1996).
13. Benekli, M., Güllü, I. H., Tekuzman, G., Savaş, M. C., Hayran, M., Hasçelik, G., Firat, D., Circulating intercellular adhesion molecule-1 and E-selectin in gastric cancer, Br. J. Cancer 78, 267 (1998).